JAK2 and myeloproliferative neoplasm: In MPN, hyperactive JAK2 signaling has been implicated in the activation of blood cells, specifically by the expression of high levels of P-selectin, adhesive integrins, tissue factor, and engagement in neutrophil extracellular trap formation, leading to enhanced interaction with the endothelium [54,55,56,57,58].